Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04990687 · ClinicalTrials.gov registry record · NA
Vagal Nerve Stimulation for Treatment Resistant Major Depression
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04990687 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 5 participants.
The verdict
NCT04990687, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to 1) explore whether vagal nerve stimulation (nVNS) using a hand- held non-invasive device (gammaCore™) works to treat depression and 2) to confirm gammaCore™'s safety profile.
Interventions
- DEVICE gammaCore™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2024-04-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04990687
The ClinicalTrials.gov registry entry for NCT04990687 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which gammaCore™ is the first listed.
NCT04990687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04990687 about?
NCT04990687 is a clinical study titled "Vagal Nerve Stimulation for Treatment Resistant Major Depression". The purpose of this study is to 1) explore whether vagal nerve stimulation (nVNS) using a hand- held non-invasive device (gammaCore™) works to treat depression and 2) to confirm gammaCore™'s safety profile.
What is the current status of trial NCT04990687?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2022-01-01. Estimated completion is 2024-04-03.
What interventions are being tested in trial NCT04990687?
The interventions under investigation include: gammaCore™ (DEVICE).
Who is sponsoring clinical trial NCT04990687?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.